Catalyst Wire Dossier Catalyst Wire Dossier

FOLFIRINOX (mFFX)

modified FOLFIRINOX
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FOLFIRINOX (mFFX), covering 2022-10-28 to 2022-10-28. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Study of FOLFIRINOX (mFFX) +/- SBRT in Locally Advanced Pancreatic Cancer [Phase 3]

See pricing